John T. Thomas - Mar 1, 2024 Form 4 Insider Report for Physicians Realty Trust (DOC)

Role
President and CEO, Director
Signature
/s/ Christopher M. Bartoli, as attorney-in-fact
Stock symbol
DOC
Transactions as of
Mar 1, 2024
Transactions value $
-$2,936,084
Form type
4
Date filed
3/1/2024, 04:13 PM
Previous filing
Jan 22, 2024
Next filing
Apr 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DOC Common shares, $0.01 par value Options Exercise +259K +37.18% 956K Mar 1, 2024 Direct F1
transaction DOC Common shares, $0.01 par value Options Exercise +245K +25.62% 1.2M Mar 1, 2024 Direct F2
transaction DOC Common shares, $0.01 par value Options Exercise +281K +23.4% 1.48M Mar 1, 2024 Direct F3
transaction DOC Common shares, $0.01 par value Tax liability -$2.94M -261K -17.64% $11.23 1.22M Mar 1, 2024 Direct
transaction DOC Common shares, $0.01 par value Disposed to Issuer -1.22M -100% 0 Mar 1, 2024 Direct F4
transaction DOC Common shares, $0.01 par value Disposed to Issuer -5.22K -100% 0 Mar 1, 2024 Represents shares held by the Reporting Person's child F4
transaction DOC Common shares, $0.01 par value Disposed to Issuer -434 -100% 0 Mar 1, 2024 Represents shares held by the Reporting Person's child F4
transaction DOC Common shares, $0.01 par value Disposed to Issuer -217 -100% 0 Mar 1, 2024 Represents shares held by the Reporting Person's child F4
transaction DOC Common shares, $0.01 par value Disposed to Issuer -217 -100% 0 Mar 1, 2024 Represents shares held by the Reporting Person's child F4
transaction DOC Common shares, $0.01 par value Disposed to Issuer -87 -100% 0 Mar 1, 2024 Represents shares held by the Reporting Person's child F4
transaction DOC Common shares, $0.01 par value Disposed to Issuer -87 -100% 0 Mar 1, 2024 Represents shares held by the Reporting Person's child F4
transaction DOC Common shares, $0.01 par value Disposed to Issuer -87 -100% 0 Mar 1, 2024 Represents shares held by the Reporting Person's child F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DOC 2020 Restricted Share Unit Grant Options Exercise $0 -259K -100% $0.00* 0 Mar 1, 2024 Common shares, $0.01 par value 259K Direct F5
transaction DOC 2022 Performance Based Restricted Share Unit Grant Options Exercise $0 -81.6K -100% $0.00* 0 Mar 1, 2024 Common shares, $0.01 par value 81.6K Direct F6
transaction DOC 2023 Performance Based Restricted Share Unit Grant Options Exercise $0 -93.7K -100% $0.00* 0 Mar 1, 2024 Common shares, $0.01 par value 93.7K Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

John T. Thomas is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive one share of the Issuer's common shares. Represents vesting of the time-based restricted stock units on March 1, 2024 pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated October 29, 2023 among the Issuer, Physicians Realty L.P., Healthpeak Properties, Inc. ("Healthpeak"), DOC DR Holdco, LLC and DOC DR LLC. The Issuer merged with and into DOC DR Holdco, LLC on March 1, 2024.
F2 Represents vesting of the 2022 Performance Based Restricted Share Units granted on March 1, 2022 under the Issuer's Equity Incentive Plan (the "Plan"). The grant vested on March 1, 2024 pursuant to the terms of the Merger Agreement dated October 29, 2023 among the Issuer, Physicians Realty L.P., Healthpeak, DOC DR Holdco, LLC and DOC DR LLC. Pursuant to the terms of the Merger Agreement, the Reporting Person received 244,932 common shares upon vesting, 300% of the target shares.
F3 Represents vesting of the 2023 Performance Based Restricted Share Units granted on March 1, 2023 under the the Plan. Pursuant to the terms of the Merger Agreement, the Reporting Person received 281,022 common shares upon vesting, 300% of the target shares.
F4 Represents securities disposed of pursuant to the terms of the the Merger Agreement and each issued and outstanding common shares of the Issuer, held by the reporting person was automatically converted into the right to receive 0.674 of a share of Healthpeak common stock, subject to any adjustment, without interest.
F5 On March 2, 2020, the Reporting Person was granted 259,067 restricted stock units, expected to vest in two equal installments on March 2, 2024 and March 2, 2025, subject to the terms of the grant. The grant vested on March 1, 2024 pursuant to the terms of the Merger Agreement.
F6 On March 1, 2022, the Reporting Person was granted 81,644 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Pursuant to the terms of the merger, the Reporting Person received 244,932 common shares upon vesting.
F7 On March 1, 2023, the Reporting Person was granted 93,674 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Pursuant to the terms of the merger, the Reporting Person received 281,022 common shares upon vesting.